Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 12:38 AM
NCT ID:
NCT06967467
Eligibility Criteria:
Inclusion Criteria:
Patient participants:
* a diagnosis of a hematologic malignancy (lymphoma, leukemia, myeloma)
* a prior label applied to their medical record to indicate a beta lactam allergy
* hospitalized as an inpatient to an oncology service at the time the study is conducted
Clinician participants:
* member of the primary inpatient care team
Exclusion Criteria:
Patient participants:
* meet one of the exclusionary criteria for the RENEW clinical intervention
Clinician participants:
* no exclusions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06967467
Study Brief:
Protocol Section:
NCT06967467